Skip to main content
Erschienen in: Lung 6/2014

01.12.2014

Selectins and Platelet-Derived Growth Factor (PDGF) in Schistosomiasis-Associated Pulmonary Hypertension

verfasst von: Monica Lapa, Milena M. P. Acencio, Alberto Q. Farias, Lisete R. Teixeira, Caio J. C. Fernandes, Carlos P. Jardim, Mario Terra-Filho

Erschienen in: Lung | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to evaluate the expression profiles of the relevant selectins and PDGF in schistosomiasis-associated pulmonary hypertension.

Methodology

Patients with three distinct clinical profiles were enrolled in the study: IPAH(n = 11), schistosomiasis-associated PH (Sch-PH))(n = 13), and schistosomiasis without PH (Sch) (n = 13). Healthy volunteers, were recruited as a control group(n = 13). Echocardiography was performed in all groups, and the PH patients underwent right heart catheterization. Plasma soluble adhesion molecules E- and P-Selectin, PDGF-AB, PDGF-BB were determined by ELISA.

Results

E-selectin was significantly increased in the IPAH group compared with the other groups [the control, Sch + PH and Sch groups) (p < 0.001) (Fig. 2)]. P-selectin was lower in Sch (20.2 + 8.9 × 103 pg/mL) as compared to the control, (43 16.8 × 103 pg/mL), IPAH (35.8 7.8 × 103 pg/mL), and Sch + PH (36.8 ± 15.7 × 103 pg/mL) (p = 0.005) groups. Serum PDGF-BB levels were higher in the control group (8.9 ± 4.8 × 103 pg/mL) compared with the IPAH (3.7 ± 2.17 × 103 pg/mL), Sch + PH (5.2 ± 3.7 × 103 pg/mL) and Sch (2.4 ± 1.7 × 103 pg/mL) groups (p < 0.05). PDGF-AB levels were also higher in the control group (25.6 ± 8.6 × 103 pg/mL), compared with the other three groups, being the Sch group the one with lower serum levels of this marker (11.4 ± 8.6 × 103 pg/mL) (p = 0.006).

Conclusions

In conclusion, vascular inflammation in schistosomiasis, with or without PH, is different from IPAH suggesting distinct pathophysiological mechanisms associated with the development of pulmonary hypertension.
Literatur
1.
2.
Zurück zum Zitat Badesch DB, Champion HC, Sanchez MAG, Hoeper MM, Loyd JE et al (2009) Diagnosis and assessment of pulmonary hypertension. J Am Coll Cardiol 54(1):255–266CrossRef Badesch DB, Champion HC, Sanchez MAG, Hoeper MM, Loyd JE et al (2009) Diagnosis and assessment of pulmonary hypertension. J Am Coll Cardiol 54(1):255–266CrossRef
4.
Zurück zum Zitat Souza R, Fernandes CJ, Jardim CV (2009) Other causes of PAH (schistosomiasis, porto-pulmonary hypertension and hemolysis-associated pulmonary hypertension). Semin Respir Crit Care Med 30(4):448–457. doi:10.1055/s-0029-1233314 CrossRefPubMed Souza R, Fernandes CJ, Jardim CV (2009) Other causes of PAH (schistosomiasis, porto-pulmonary hypertension and hemolysis-associated pulmonary hypertension). Semin Respir Crit Care Med 30(4):448–457. doi:10.​1055/​s-0029-1233314 CrossRefPubMed
5.
Zurück zum Zitat Lapa MS, Dias B, Jardim C, Fernandes CJC, Dourado P, Figueiredo M, Farias A, Tutsui J, Terra-Filho M, Humbert M, Souza R (2009) Cardiopulmonary manifestations of hepatosplenic schistosomiasis. Circulation 119:1518–1523CrossRefPubMed Lapa MS, Dias B, Jardim C, Fernandes CJC, Dourado P, Figueiredo M, Farias A, Tutsui J, Terra-Filho M, Humbert M, Souza R (2009) Cardiopulmonary manifestations of hepatosplenic schistosomiasis. Circulation 119:1518–1523CrossRefPubMed
6.
Zurück zum Zitat Butrous G, Ghofrani HA, Grimminger F (2008) Pulmonary vascular disease in the developing world. Circulation 118:1758–1766CrossRefPubMed Butrous G, Ghofrani HA, Grimminger F (2008) Pulmonary vascular disease in the developing world. Circulation 118:1758–1766CrossRefPubMed
7.
Zurück zum Zitat Conceição MJ, Borges-Pereira J, Coura JR (2007) A thirty years follow-up study on Schistosomiasis mansoni in a community of Minas Gerais, Brazil. Mem Inst Oswaldo Cruz 102(8):1007–1009CrossRefPubMed Conceição MJ, Borges-Pereira J, Coura JR (2007) A thirty years follow-up study on Schistosomiasis mansoni in a community of Minas Gerais, Brazil. Mem Inst Oswaldo Cruz 102(8):1007–1009CrossRefPubMed
8.
Zurück zum Zitat Lambertucci JR, Serufo JC, Gerspacher-Lara R, Rayes AAM et al (2000) Schistosoma mansoni: assessment of morbidity before and after control. Acta Trop 77:101–109CrossRefPubMed Lambertucci JR, Serufo JC, Gerspacher-Lara R, Rayes AAM et al (2000) Schistosoma mansoni: assessment of morbidity before and after control. Acta Trop 77:101–109CrossRefPubMed
9.
Zurück zum Zitat Fernandes CJCS, Jardim CVP, Hovnanian A, Hoette S, Dias BA, Souza S, Humbert M, Souza R (2010) Survival in schistosomiasis-associated pulmonary arterial hypertension. J Am Coll Cardiol 56:715–720CrossRef Fernandes CJCS, Jardim CVP, Hovnanian A, Hoette S, Dias BA, Souza S, Humbert M, Souza R (2010) Survival in schistosomiasis-associated pulmonary arterial hypertension. J Am Coll Cardiol 56:715–720CrossRef
10.
Zurück zum Zitat Cahill PARE, Sitzmann JV (2001) Endothelial dysfunction in cirrhosis and portal hypertension. Pharmacol Ther 89:273–293 (2001)CrossRefPubMed Cahill PARE, Sitzmann JV (2001) Endothelial dysfunction in cirrhosis and portal hypertension. Pharmacol Ther 89:273–293 (2001)CrossRefPubMed
11.
Zurück zum Zitat Richter J (2000) Evolution of schistosomiasis-induced pathology after therapy and interruption of exposure to schistosomes: a review of ultrasonographic studies. Acta Trop 77:111–131CrossRefPubMed Richter J (2000) Evolution of schistosomiasis-induced pathology after therapy and interruption of exposure to schistosomes: a review of ultrasonographic studies. Acta Trop 77:111–131CrossRefPubMed
12.
Zurück zum Zitat Cichoz-Lach HCK, Stomka M, Kasztelan-Szczerbinska B (2008) Pathophysiology of portal hypertension. J Physiol Pharmacol 59(Suppl 2):231–238 Cichoz-Lach HCK, Stomka M, Kasztelan-Szczerbinska B (2008) Pathophysiology of portal hypertension. J Physiol Pharmacol 59(Suppl 2):231–238
13.
Zurück zum Zitat Cella G, Belloto F, Tona F, Sbarai A, Mazzaro G, Motta G, Fareed J (2001) Plasma markers of endothelial dysfunction in pulmonary hypertension. Chest 120:1226–1230CrossRefPubMed Cella G, Belloto F, Tona F, Sbarai A, Mazzaro G, Motta G, Fareed J (2001) Plasma markers of endothelial dysfunction in pulmonary hypertension. Chest 120:1226–1230CrossRefPubMed
14.
Zurück zum Zitat Morrel NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA, Weissmann N, Yuan JX-Y, Weir EK (2009) Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 54(1):s20–s31. doi:10.1016/j.jacc.2009.04.018 CrossRef Morrel NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA, Weissmann N, Yuan JX-Y, Weir EK (2009) Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 54(1):s20–s31. doi:10.​1016/​j.​jacc.​2009.​04.​018 CrossRef
15.
Zurück zum Zitat Graham BB, Bandeira AP, Morrell NW, Butrous G, Tuder RM (2010) Schistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspective. Chest 137(6 Suppl):20s–29sCrossRefPubMed Graham BB, Bandeira AP, Morrell NW, Butrous G, Tuder RM (2010) Schistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspective. Chest 137(6 Suppl):20s–29sCrossRefPubMed
16.
Zurück zum Zitat Barrier M, Meloche J, Jacob MH, Courboulin A, Provencher S, Bonnet S (2012) Today’s and tomorrow’s imaging and circulating biomarkers for pulmonary arterial hypertension. Cell Mol Life Sci 69(17):2805–2831. doi:10.1007/s00018-012-0950-4 CrossRefPubMed Barrier M, Meloche J, Jacob MH, Courboulin A, Provencher S, Bonnet S (2012) Today’s and tomorrow’s imaging and circulating biomarkers for pulmonary arterial hypertension. Cell Mol Life Sci 69(17):2805–2831. doi:10.​1007/​s00018-012-0950-4 CrossRefPubMed
17.
Zurück zum Zitat Budhiraja R, Tuder RM, Hassoun PM (2004) Endothelial dysfunction in pulmonary hypertension. Circulation 109:159–165CrossRefPubMed Budhiraja R, Tuder RM, Hassoun PM (2004) Endothelial dysfunction in pulmonary hypertension. Circulation 109:159–165CrossRefPubMed
18.
Zurück zum Zitat Perros F, Montani D, Dorfmuller P, Durand-Gasselin I, Tcherakian C, Le Pavec J, Mazmanian M, Fadel E, Mussot S, Mercier O, Herve P, Emilie D, Eddahibi S, Simonneau G, Souza R, Humbert M (2007) Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 178(1):81–88. doi:10.1164/rccm.200707-1037OC07-1037OC CrossRef Perros F, Montani D, Dorfmuller P, Durand-Gasselin I, Tcherakian C, Le Pavec J, Mazmanian M, Fadel E, Mussot S, Mercier O, Herve P, Emilie D, Eddahibi S, Simonneau G, Souza R, Humbert M (2007) Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 178(1):81–88. doi:10.​1164/​rccm.​200707-1037OC07-1037OC CrossRef
19.
Zurück zum Zitat Trottein F, Nutten S, Angeli V, Delerive P et al (1999) Schistosoma mansoni schistosomula reduce E-selectin and VCAM-1 expression in TNF-alpha-stimulated lung microvascular endothelial cells by interfering with NF-kappaB pathway. Eur J Immunol 29:3691–3701CrossRefPubMed Trottein F, Nutten S, Angeli V, Delerive P et al (1999) Schistosoma mansoni schistosomula reduce E-selectin and VCAM-1 expression in TNF-alpha-stimulated lung microvascular endothelial cells by interfering with NF-kappaB pathway. Eur J Immunol 29:3691–3701CrossRefPubMed
20.
Zurück zum Zitat Soares S, Rodrigues-Junior V, Silva DTN, Moraes-Souza H (2007) Participation of platelets in the process of fibrosis in patients with mansonic schistosomiasis. schistosomiasis. Rev Soc Bras Med Trop 40(3):321–325CrossRefPubMed Soares S, Rodrigues-Junior V, Silva DTN, Moraes-Souza H (2007) Participation of platelets in the process of fibrosis in patients with mansonic schistosomiasis. schistosomiasis. Rev Soc Bras Med Trop 40(3):321–325CrossRefPubMed
21.
Zurück zum Zitat Vezozzo DCP, Farias AQ, Cerri GG, da Silva LC, Carrilho FJ (2006) Assessment of portal hemodynamics by doppler ultrasound and of liver morphology in the hepatospleinc and hepatointestinal forms of Schistosomiasis mansoni. Dig Dis Sci 51:1413–1419CrossRefPubMed Vezozzo DCP, Farias AQ, Cerri GG, da Silva LC, Carrilho FJ (2006) Assessment of portal hemodynamics by doppler ultrasound and of liver morphology in the hepatospleinc and hepatointestinal forms of Schistosomiasis mansoni. Dig Dis Sci 51:1413–1419CrossRefPubMed
22.
Zurück zum Zitat Hatz C, Jenkins JM, Ali QM, Abdel-Wahab MF, Cerri GG, Tanner M (1992) A review of the literature on the use of ultrasonography in schistosomiasis with special reference to its use in field studies. 2. Schistosoma mansoni. Acta Trop 51:15–28CrossRefPubMed Hatz C, Jenkins JM, Ali QM, Abdel-Wahab MF, Cerri GG, Tanner M (1992) A review of the literature on the use of ultrasonography in schistosomiasis with special reference to its use in field studies. 2. Schistosoma mansoni. Acta Trop 51:15–28CrossRefPubMed
23.
Zurück zum Zitat Pereira CA, Sato T, Rodrigues SC (2007) New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 33(4):397–406CrossRefPubMed Pereira CA, Sato T, Rodrigues SC (2007) New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 33(4):397–406CrossRefPubMed
24.
Zurück zum Zitat Simmonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliot CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R (2009) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54(1):S43–S54CrossRef Simmonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliot CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R (2009) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54(1):S43–S54CrossRef
25.
Zurück zum Zitat Costa EL, Jardim C, Bogossian HB, Amato MB, Carvalho CR, Souza R (2005) Acute vasodilator test in pulmonary arterial hypertension: evaluation of two response criteria. Vasc Pharmacol 43(3):143–147. doi:10.1016/j.vph.2005.05.004 CrossRef Costa EL, Jardim C, Bogossian HB, Amato MB, Carvalho CR, Souza R (2005) Acute vasodilator test in pulmonary arterial hypertension: evaluation of two response criteria. Vasc Pharmacol 43(3):143–147. doi:10.​1016/​j.​vph.​2005.​05.​004 CrossRef
26.
Zurück zum Zitat Rather LJ, Virchow RLK, Schwalbe J (1990) A commentary on the medical writings of Rudolf Virchow: based on Schwalbe’s Virchow-Bibliographie, 1843–1901. Norman Publishing Rather LJ, Virchow RLK, Schwalbe J (1990) A commentary on the medical writings of Rudolf Virchow: based on Schwalbe’s Virchow-Bibliographie, 1843–1901. Norman Publishing
27.
Zurück zum Zitat Witters P, Freson K, Verslype C, Peerkink K, Hoylaerts M, Nevens F, Van Geet C, Cassiman D (2008) Review article: blood platelet count number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther 27:1017–1029CrossRefPubMed Witters P, Freson K, Verslype C, Peerkink K, Hoylaerts M, Nevens F, Van Geet C, Cassiman D (2008) Review article: blood platelet count number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther 27:1017–1029CrossRefPubMed
28.
Zurück zum Zitat Eddahibi E, Humbert M, Sediame S, Chouaid C et al (2000) Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Am J Respir Crit Care Med 162:1493–1499CrossRefPubMed Eddahibi E, Humbert M, Sediame S, Chouaid C et al (2000) Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Am J Respir Crit Care Med 162:1493–1499CrossRefPubMed
29.
Metadaten
Titel
Selectins and Platelet-Derived Growth Factor (PDGF) in Schistosomiasis-Associated Pulmonary Hypertension
verfasst von
Monica Lapa
Milena M. P. Acencio
Alberto Q. Farias
Lisete R. Teixeira
Caio J. C. Fernandes
Carlos P. Jardim
Mario Terra-Filho
Publikationsdatum
01.12.2014
Verlag
Springer US
Erschienen in
Lung / Ausgabe 6/2014
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-014-9643-0

Weitere Artikel der Ausgabe 6/2014

Lung 6/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

RAS-Blocker bei Hyperkaliämie möglichst nicht sofort absetzen

14.05.2024 Hyperkaliämie Nachrichten

Bei ausgeprägter Nierenfunktionsstörung steigen unter der Einnahme von Renin-Angiotensin-System(RAS)-Hemmstoffen nicht selten die Serumkaliumspiegel. Was in diesem Fall zu tun ist, erklärte Prof. Jürgen Floege beim diesjährigen Allgemeinmedizin-Update-Seminar.

Shunt-Therapie bei Herzinsuffizienz: Kein Anzug, der allen passt

13.05.2024 Chronische Herzinsuffizienz Nachrichten

Die Anlage eines interatrialen Shunts zur Reduktion des linksatrialen Drucks ist ein neuer Therapieansatz bei Herzinsuffizienz. Viele Patienten sprechen darauf an, andere jedoch nicht. 

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.